Seeking Alpha

AIM ImmunoTech to Participate in Solve M.E. and The Biotechnology Innovation Organization (BIO) Virtual Event, “Long Covid: What Will It Take To Accelerate Therapeutic ...

OCALA, Fla., Feb. 17, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple ...
Seeking Alpha

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

OCALA, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Japan Patent Office has issued a patent covering the ...
Hosted on MSN

Scientists aim to speed up cancer vaccine discovery using AI

Oxford scientists are aiming to speed up cancer vaccine discovery using advanced technology. The University of Oxford has launched the AI Cancer Scientist, a research project that will combine ...
Medical News Today

AI-ready open database aims to accelerate cancer immunotherapy research

Share on Pinterest The novel AI-ready database could help to accelerate cancer immunotherapy research. Image credit: Assembly/Getty Images The Cancer Research Institute (CRI) launches a ...